Loading
Latest filing published 17 Jul 2026 for GSK plc, €1,051. Read the official filing
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Dr Jeannie Lee appears in our data through filings on GSK plc shares, published by RNS (LSE). In total, 20 filings cover trades dated from 20 June 2024 to 10 July 2026.
On the market, this insider has only ever bought: 11 purchases, €199k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 9 share grants. Since January 2026: 3 purchases and no sales on the market.
A typical purchase (the median) is worth €11k. 9 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 17 July 2026: a share grant of €1,051, in GSK plc. The most recent open-market purchase was published on 24 June 2026, 115 days ago. Typically, a trade is published a median of 3 days after it takes place. The regulation allows three business days to notify a trade (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations